Details van artikel 227 van 340 gevonden artikelen
Phase II Feasibility Study of Adjuvant S-1 Plus Docetaxel Repeated for 6 Months as Adjuvant Chemotherapy for Stage III Gastric Cancer After Curative D2 Gastrectomy (OGSG 1002)
Titel:
Phase II Feasibility Study of Adjuvant S-1 Plus Docetaxel Repeated for 6 Months as Adjuvant Chemotherapy for Stage III Gastric Cancer After Curative D2 Gastrectomy (OGSG 1002)